24.38
Precedente Chiudi:
$23.11
Aprire:
$23.48
Volume 24 ore:
26,721
Relative Volume:
0.48
Capitalizzazione di mercato:
$1.07B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-4.89%
1M Prestazione:
+7.21%
6M Prestazione:
-48.17%
1 anno Prestazione:
+282.20%
Anbio Biotechnology Stock (NNNN) Company Profile
Nome
Anbio Biotechnology
Settore
Industria
Telefono
-
Indirizzo
-
Compare NNNN vs ISRG, BDX, ALC, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
NNNN
Anbio Biotechnology
|
24.38 | 1.01B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
502.13 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.26 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
84.01 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.90 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
43.16 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Anbio Biotechnology Borsa (NNNN) Ultime notizie
Veritone (NASDAQ:VERI) Given Buy Rating at D. Boral Capital - Defense World
TechTarget (TTGT) to Release Earnings on Wednesday - Defense World
Head to Head Contrast: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Anbio Biotechnology: Improved Margins, Still Priced For Growth That Isn't Showing Up - Seeking Alpha
NNNN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head to Head Contrast - Defense World
NNNN Technical Analysis & Stock Price Forecast - Intellectia AI
NNNN Should I Buy - Intellectia AI
Anbio Biotechnology (NNNN) Stock Analysis: Navigating Volatility in the Medical Instruments Sector - DirectorsTalk Interviews
Critical Comparison: Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Celestica Inc. (TSE:CLS) Receives Average Recommendation of “Strong Buy” from Analysts - Defense World
Comparing Anbio Biotechnology (NASDAQ:NNNN) & Oncocyte (NASDAQ:IMDX) - Defense World
Head-To-Head Survey: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Reviewing Anbio Biotechnology (NASDAQ:NNNN) and Oncocyte (NASDAQ:IMDX) - Defense World
Diane Lazzaris Sells 2,747 Shares of WESCO International (NYSE:WCC) Stock - Defense World
Anbio Biotechnology (NNNN) Stock Analysis: What Investors Should Know About This German IVD Innovator - DirectorsTalk Interviews
Anbio Biotechnology prices $8M IPO at $5 per share - MSN
Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN) Critical Comparison - Defense World
Anbio Biotechnology Replaces Auditor to Safeguard 2025 Reporting Timeline - TipRanks
Head-To-Head Comparison: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
IPO window reopens, med-tech class of 2025 gains 26% - bioworld.com
Head to Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
COREwafer Industries Inc. (OTCMKTS:AHIX) Short Interest Up 126.9% in January - Defense World
GRAIL (GRAL) Projected to Post Earnings on Thursday - Defense World
Anbio Biotechnology (NASDAQ:NNNN) Stock Price Up 8.4%Should You Buy? - MarketBeat
Contrasting Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Financial Survey: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Financial Comparison: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Anbio Biotechnology and Oncocyte: A Financial Review - National Today
Critical Analysis: Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) - Defense World
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Anbio Biotechnology Class A Shares Took Off - TipRanks
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Anbio Biotechnology Class A Shares Surge After Volatility Pause - TipRanks
Disney, Micron Tech among market cap stock movers on Monday - Investing.com
Why Anbio Biotechnology Class A Shares Are Surging - TipRanks
InvestingPro’s overvalued warning saved investors from 54% Anbio Bio crash By Investing.com - Investing.com South Africa
Anbio Biotechnology (NNNN) Stock Trends and Sentiment 2026 - MarketBeat
Intel, Oracle among market cap stock movers on Monday By Investing.com - Investing.com Nigeria
Anbio Biotechnology Strengthens Board Oversight With Appointment of Michael Zhang as Audit Committee Chair - TipRanks
Anbio Biotechnology Announces Board and Committee Changes, Effective January 21, 2026 - marketscreener.com
Anbio Biotechnology (NNNN) Stock Analysis: A Rollercoaster Year With Growth Potential - DirectorsTalk Interviews
NNNN Forecast — Price Prediction for 2026. Should I Buy NNNN? - Intellectia AI
Industries Limited Rebound Backed by Sentiment ShiftMACD Trading Signals & Technical + Fundamental = Smarter Investing - bollywoodhelpline.com
S&P 500 Futures Up in Premarket Trading; QXO, Mosaic Lag - Barron's
Anbio Biotechnology falls -5.8% - MSN
Anbio Biotechnology (NASDAQ:NNNN) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - simplywall.st
Anbio Biotechnology's (NASDAQ:NNNN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - Yahoo Finance
Anbio Biotechnology (NNNN) Stock Analysis: Navigating the 52-Week Surge in a Volatile Market - DirectorsTalk Interviews
Anbio Biotechnology Posts Higher Margins and Profits Despite Revenue Dip in First Half of 2025 - The Globe and Mail
Intel, Oracle among market cap stock movers on Monday - Investing.com
Anbio Biotechnology Azioni (NNNN) Dati Finanziari
Non sono disponibili dati finanziari per Anbio Biotechnology (NNNN). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):